AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
View complete overview of AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Costs
Summary
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Rivaroxaban (b01af01), In Der Wirkstärke 2,5 Mg Je Abgeteilte Darreichungsform Im Rahmen Eines Sogenannten Open-house-modells.
Description
Scription for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user
Contact
Tender Id
104599-2024Tender No
104599-2024Tender Authority
AOK Rheinland Pfalz Saarland Die Gesundheitskasse ViewPurchaser Address
-Website
http://www.aok.de/rheinland-pfalz-saarland/
Documents